Literature DB >> 10577640

Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.

B Ramratnam1, S Bonhoeffer, J Binley, A Hurley, L Zhang, J E Mittler, M Markowitz, J P Moore, A S Perelson, D D Ho.   

Abstract

BACKGROUND: In chronic HIV-1 infection, dynamic equilibrium exists between viral production and clearance. The half-life of free virions can be estimated by inhibiting virion production with antiretroviral agents and modelling the resulting decline in plasma HIV-1 RNA. To define HIV-1 and hepatitis C virus (HCV) dynamics, we used plasma apheresis to increase virion clearance temporarily while leaving virion production unaffected.
METHODS: Plasma virus loads were measured frequently before, during, and after apheresis in four HIV-1-infected patients, two of whom were also co-infected with HCV. Rates of virion clearance were derived by non-linear least-square fitting of plasma virus load to a model of viral dynamics.
FINDINGS: Virion clearance rate constants were 0.0063/min (9.1/day) to 0.025/min (36.0/day; half-life 28-110 min) for HIV-1 and 0.0038/min (5.5/day) to 0.0069/min (9.9/day; half-life 100-182 min) for HCV. These values provided estimates of daily particle production of 9.3 log10-10.2 log10 particles for HIV-1 and 11.6 log10-13.0 log10 particles for HCV.
INTERPRETATION: Our findings confirm that HIV-1 and HCV are produced and cleared extremely rapidly. New estimates for HIV-1 clearance are up to ten times higher than previous ones, whereas HCV clearance is similar to previous estimates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577640     DOI: 10.1016/S0140-6736(99)02035-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  187 in total

1.  Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy.

Authors:  W S Hlavacek; N I Stilianakis; D W Notermans; S A Danner; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells.

Authors:  G G Olinger; M Saifuddin; G T Spear
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Persistence and emergence of X4 virus in HIV infection.

Authors:  Ariel D Weinberger; Alan S Perelson
Journal:  Math Biosci Eng       Date:  2011-04       Impact factor: 2.080

4.  Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA.

Authors:  Oliver Pusch; Daniel Boden; Rebecca Silbermann; Fred Lee; Lynne Tucker; Bharat Ramratnam
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

5.  Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.

Authors:  Viktor Müller; Javier Flavio Vigueras-Gómez; Sebastian Bonhoeffer
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  Procedures for reliable estimation of viral fitness from time-series data.

Authors:  Sebastian Bonhoeffer; Andrew D Barbour; Rob J De Boer
Journal:  Proc Biol Sci       Date:  2002-09-22       Impact factor: 5.349

7.  Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection.

Authors:  Miles P Davenport; Ruy M Ribeiro; Alan S Perelson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Impaired immune evasion in HIV through intracellular delays and multiple infection of cells.

Authors:  Christian L Althaus; Rob J De Boer
Journal:  Proc Biol Sci       Date:  2012-04-04       Impact factor: 5.349

9.  Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly.

Authors:  Wolfgang Resch; Rainer Ziermann; Neil Parkin; Andrea Gamarnik; Ronald Swanstrom
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Effect of ribavirin and amantadine on early hepatitis C virus RNA rebound and clearance in serum during daily high-dose interferon.

Authors:  Gerond Lake-Bakaar; Lynda Ruffini; Petr Kuzmic
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.